On May 10, 2026, the National Brain-Computer Interface Science, Technology and Industry Integration Innovation Conference was successfully held in Nanjing. Themed "Intelligent BCI, Exploring the Future," the conference gathered nearly 30 academicians from both academies, over 60 clinical experts, and more than a thousand representatives from industry, academia, research, medicine, and capital to jointly outline the blueprint for BCI technology innovation and industrial transformation. Hangzhou NEUREAL Technology Co., Ltd. (hereinafter referred to as NEUREAL), invited as a benchmark enterprise in the #BCI + brain disease treatment and rehabilitation field, showcased its BCI+X Precision Diagnosis and Treatment Platform for Brain Disorders, presenting cutting-edge achievements in non-invasive brain-computer interface technology to the industry.
A Premier Event Outlining a New Blueprint for the BCI Industry
Jointly organized by authoritative institutions including the Institute of Brain-Computer Interfaces at Nanjing University and the National Innovation Center for High-Performance Medical Devices, the conference adopted a structure of "one main forum plus four sub-forums." Focusing on BCI technological breakthroughs, clinical medical practice, collaborative industrial innovation, and investment implementation, the event comprehensively promoted the transition of BCI technology from laboratory to clinical application, and from conceptualization to reality.
As an industry trendsetter in domestic neuroscience and BCI, the conference not only featured frontier research results from top institutions such as Tsinghua University and the Chinese Academy of Sciences (CAS), but also attracted benchmark enterprises in national medical technology and digital therapeutics. It presented a full-industry-chain technology matrix covering BCI, neuromodulation, VR rehabilitation, etc., building a core platform for technical exchange, resource matching, and ecosystem co-construction.
NEUREAL: Deep Cultivation in the BCI+VR Neuroscience Healthcare Track
As China's first medical technology company driven by BCI+X, NEUREAL exhibited its BCI+X Precision Diagnosis and Treatment Platform for Brain Disorders at this expo. At the venue, the company focused on applications of BCI in core clinical scenarios such as neurological rehabilitation, psychiatric intervention, and cognitive enhancement. It engaged in in-depth exchanges with hospital experts, industry partners, and investment institutions, sharing practical experience and technical advantages of deeply integrated BCI+VR and AI technologies in fields like post-stroke rehabilitation, geriatric cognitive impairment, and pediatric Attention Deficit Hyperactivity Disorder (ADHD).
With years of deep cultivation in chronic brain disorders, NEUREAL has always adhered to the vision of "Expanding the Digital Dimension of Life" and the mission of "Improving Human Brain Health through Technology." Driven by innovative technology, it focuses on the R&D and implementation of medical-grade BCI products. Through the deep integration of multiple technologies including AI, BCI, VR, DCBT, and transcranial Direct Current Stimulation (tDCS), it accelerates scientific exploration and personalized treatment for brain disorders, helping patients achieve functional reconstruction and improved quality of life. This exhibition represents both NEUREAL's deep insight into industry trends and a significant opportunity for collaborative exchange across the supply chain to promote technology transfer.
Syncing with Industry Pulse, Building a Future Brain Health Ecosystem Together
As a national strategic frontier technology, BCI is accelerating its integration into healthcare. The insights from this conference align closely with NEUREAL's development path. By pushing the boundaries of non-invasive BCI and multi-modal fusion, NEUREAL aims to contribute to the construction of a comprehensive brain health ecosystem, ensuring that advanced technologies truly benefit patients and society.
Looking ahead, NEUREAL will continue to deepen its commitment to innovation and collaboration, working with partners across the industry to advance the application of BCI in psychiatric care, neurological rehabilitation, and smart eldercare, ultimately fostering a healthier future for human brains.
